Ke Yan Loo

Ms. Ke Yan Loo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
KLKe Yan Loo
Ke Yan Loo
VLVengadesh Letchumanan
Vengadesh Letchumanan
HSHooi-Leng Ser
Hooi-Leng Ser
STSiew Li Teoh
Siew Li Teoh
Jodi Woan-Fei Law LawJodi Woan-Fei Law Law
Jodi Woan-Fei Law Law
Learn-Han LeeLearn-Han Lee
Learn-Han Lee
People around the world ushered in the new year 2021 with a fear of COVID-19, as family members have lost their loved ones to the disease. Millions of people have been infected, and the livelihood of many has been jeopardized due to the pandemic. Pharmaceutical companies are racing against time to develop an effective vaccine to protect against COVID-19. Researchers have developed various types of candidate vaccines with the release of the genetic sequence of the SARS-CoV-2 virus in January. These include inactivated viral vaccines, protein subunit vaccines, mRNA vaccines, and recombinant viral vector vaccines. To date, several vaccines have been authorized for emergency use and they have been administered in countries across the globe. Meanwhile, there are also vaccine candidates in Phase III clinical trials awaiting results and approval from authorities. These candidates have shown positive results in the previous stages of the trials, whereby they could induce an immune response with minimal side effects in the participants. This review aims to discuss the different vaccine platforms and the clinical trials of the candidate vaccines.

4 January 2023 in Progress In Microbes & Molecular Biology
Verified
Journal Article
Open access
PDF file
IOIsaac Jingkhai Ong
Isaac Jingkhai Ong
KLKe Yan Loo
Ke Yan Loo
LLLYDIA NGIIK SHIEW LAW
LYDIA NGIIK SHIEW LAW
Jodi Woan-Fei Law LawJodi Woan-Fei Law Law
Jodi Woan-Fei Law Law
Loh Teng-Hern TanLoh Teng-Hern Tan
Loh Teng-Hern Tan
VLVengadesh Letchumanan
Vengadesh Letchumanan
Helicobacter pylori is a highly prevalent bacteria that can harm humans due to its major involvement in developing gastrointestinal diseases, particularly gastric cancer. Therefore, eradicating H. pylori is one of the most important strategies for preventing gastric cancer. Antibiotic treatment has always been the gold standard treatment for H. pylori infection. However, the decreasing efficacy of antibiotic therapy due to the rising antibiotic resistance and high incidence of dysbiosis-related adverse effects resulted in eradication failure. To enhance the effectiveness of antibiotic therapy, strategies that modulate the gut microbiome were proposed to play a positive role. Generally, the integration of probiotics or symbiotic into antibiotic therapy was shown to enhance the eradication rate and reduce the incidence of adverse effects. This review aims to discuss the role and effect of H. pylori in gastric carcinogenesis and gut microbiome modulation in eradicating H. pylori infection.

4 January 2023 in Progress In Microbes & Molecular Biology
Verified
Journal Article
Open access
PDF file
KLKe Yan Loo
Ke Yan Loo
Loh Teng-Hern TanLoh Teng-Hern Tan
Loh Teng-Hern Tan
Jodi Woan-Fei Law LawJodi Woan-Fei Law Law
Jodi Woan-Fei Law Law
PPPriyia Pusparajah
Priyia Pusparajah
Learn-Han LeeLearn-Han Lee
Learn-Han Lee
VLVengadesh Letchumanan
Vengadesh Letchumanan
The growing global population has increased the demand for seafood, making the aquaculture industry a vital food source. However, climate change has negatively impacted the industry as natural inhabitants of aquatic environments such as Vibrio parahaemolyticus are thriving in the warming waters. These foodborne pathogens can cause disease in marine animals, resulting in lowered production rates and substantial economic losses. V. parahaemolyticus is transmitted from these marine animals in aquaculture to humans via raw or undercooked seafood, resulting in gastroenteritis outbreaks. In addition, the extensive use of antibiotics in aquaculture to treat infections within marine animals has led to the development of multidrug-resistant (MDR) V. parahaemolyticus, which threatens the effectiveness of antimicrobial treatments. Thus, it is vital to explore the alternatives of antibiotics in aquaculture to manage the spread of antibiotic resistance. This study aimed to investigate the prevalence of MDR V. parahaemolyticus to provide insight into the current antibiotic resistance patterns of this pathogen and to determine potential anti-Vibrio properties of Streptomyces MUM 178J which was previously isolated from the soils of a mangrove forest in Sarawak, Malaysia. Colony morphology and toxR-assay indicated that all samples tested positive for V. parahaemolyticus. Further identification with genomic analyses confirmed that 64% (64/100) of the isolates were V. parahaemolyticus. The multiple antibiotic resistance index (MAR) of the isolates ranged between 0.07 and 0.57, with 81% (52/64) of the isolates resistant to more than one antibiotic. The isolates were most resistant to ampicillin (98.4%), followed by ceftazidime (53.1%). In contrast, the isolates were highly susceptible to nalidixic acid (98.4%), tetracycline (93.8%), and sulfamethoxazole/trimethoprim (90.6%). They also demonstrated susceptibilities of 89.1% to levofloxacin, oxytetracycline, and gentamicin. Streptomyces sp. MUM 178J exhibited antagonistic effects on select V. parahaemolyticus strain, RP0132, with a minimum inhibitory concentration of 12.5 mg/mL and a minimum bactericidal concentration of 50 mg/mL.

4 January 2023 in Progress In Microbes & Molecular Biology
Verified
Journal Article
Open access
PDF file
KLKe Yan Loo
Ke Yan Loo
Jodi Woan-Fei Law LawJodi Woan-Fei Law Law
Jodi Woan-Fei Law Law
Loh Teng-Hern TanLoh Teng-Hern Tan
Loh Teng-Hern Tan
PPPriyia Pusparajah
Priyia Pusparajah
SWSunny Wong
Sunny Wong
VLVengadesh Letchumanan
Vengadesh Letchumanan
Vibrios are a group of Gram-negative bacteria ubiquitous in our surrounding environments and responsible for various clinically significant human infections. The three species responsible for human illness are Vibrio cholerae, Vibrio parahaemolyticus, and Vibrio vulnificus. V. cholerae causes cholera which may result in severe dehydration and death without timely treatment, V. parahaemolyticus infection causes gastroenteritis while V. vulnificus infections typically manifest as wound or soft tissue infections with poor prognosis, including amputation or death. Available data on the epidemiology and clinical burden of Vibrio infections were compiled systematically following a literature review, and 149 relevant studies published between 2010 to 2022 were identified. Cholera represents the majority of Vibrio infections, affecting individuals of all ages and gender, while V. parahaemolyticus infections were found to affect mostly adult males. V. vulnificus infections were mostly reported in males over 50 years old with pre-existing co-morbidities. This review's findings may guide planning and implementing preventative measures in affected regions to prevent future Vibrio infections, disease transmission, and major outbreaks.

20 January 2022 in Progress In Microbes & Molecular Biology
Verified
Journal Article
Open access
PDF file
KLKe Yan Loo
Ke Yan Loo
VLVengadesh Letchumanan
Vengadesh Letchumanan
The novel coronavirus, SARS-CoV-2, part of the Coronaviridae family, was discovered in December 2019 in China. World Health Organization named it COVID-19 and by March 2020, it had spread worldwide, causing a global pandemic. Despite continuous efforts to prevent the spread of the virus, the virus seemed always to be a step ahead of humankind as it rapidly evolved to produce new variants. These variants have higher transmissibility than the original virus and were responsible for new waves of infections. The first variant was Alpha, followed by the discovery of Beta, Gamma, Delta, and Omicron, being the latest variant of concern. Although vaccines were distributed worldwide to reduce the severity of the disease when infected with SARS-CoV-2, the emergence of new variants raised doubts about the efficacy of the available vaccines. Studies showed a decrease in neutralizing antibodies during infection with XBB and BQ subvariants compared to infections caused by other variants. Fortunately, early evidence shows that the mRNA vaccines are still effective against the current circulating Omicron sublineages of the coronavirus. Nevertheless, continuous genomic surveillance of the coronavirus is still important to detect any new variants of concern to assess their potential to threaten public health. The efficacy of vaccines and treatment options available against the latest circulating variant of SARS-CoV-2 should also be periodically evaluated. This ensures that the treatment and vaccines used are safe and effective against the virus to protect the public from another health crisis.

4 January 2023 in Progress In Microbes & Molecular Biology
Verified
Journal Article
Open access
PDF file
KLKe Yan Loo
Ke Yan Loo
Loh Teng-Hern TanLoh Teng-Hern Tan
Loh Teng-Hern Tan
Jodi Woan-Fei Law LawJodi Woan-Fei Law Law
Jodi Woan-Fei Law Law
PPPriyia Pusparajah
Priyia Pusparajah
SWSunny Wong
Sunny Wong
VLVengadesh Letchumanan
Vengadesh Letchumanan
As the world recovers from the COVID-19 pandemic, concern remains for future potential outbreaks because of the persisting effects of climate change, including the proliferation of infectious diseases. The frequent isolation of Vibrio parahaemolyticus in the surrounding environment is of concern as it can cause infections in marine animals and transmitted to humans. V. parahaemolyticus is the leading cause of foodborne gastroenteritis worldwide. Malaysia is one of the top seafood consumers and this places us at a higher risk of exposure to V. parahaemolyticus infections. Over the years, this foodborne pathogen has been isolated from various sources in Malaysia, mainly from seafood such as shellfish, shrimps, and fish. To make matters worse, there has been an emergence of antibiotic-resistant V. parahaemolyticus worldwide, which is attributed to the uncontrolled use of antibiotics in aquaculture to prevent and treat vibriosis. Therefore, it is vital to utilize alternatives such as probiotics to control V. parahaemolyticus to prevent further propagation of antibiotic-resistant strains of the bacteria. A potential candidate for probiotics is Streptomyces sp., a class of filamentous, Gram-positive bacteria that produce a variety of bioactive compounds during their life cycle, which can be useful in drug discovery. The bioactive compounds produced by Streptomyces sp. have been proven to have microbiota-modulating and stimulatory effects on the host, enhancing immunity and providing protective effects against V. parahaemolyticus infections. With the application of Streptomyces sp. as probiotics in aquaculture, the efficacy of the available antibiotics can be preserved, and the further spread of antibiotic resistance in the environment can be reduced.